ARTICLE | Clinical News
Cell Genesys preclinical data
November 15, 1999 8:00 AM UTC
CEGE and partner Mitotix Inc. (Cambridge, Mass.) reported a 50 percent reduction in the proliferation of smooth muscle cells following angioplasty in blood vessels treated with p27/p16 gene therapy i...